Attached files
| file | filename |
|---|---|
| 10-K/A - NORTHWEST BIOTHERAPEUTICS INC | v208904_10ka.htm |
| EX-23 - NORTHWEST BIOTHERAPEUTICS INC | v208904_ex23.htm |
| EX-31.1 - NORTHWEST BIOTHERAPEUTICS INC | v208904_ex31-1.htm |
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS
ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002
In
connection with the Annual Report of Northwest Biotherapeutics, Inc. and
its subsidiary (the “Company”) on Form 10-K for the year ended
December 31, 2009, as filed with the Securities and Exchange Commission
(the "Report"), I, Alton L. Boynton certify pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
|
|
(1)
|
The Report fully complies with
the requirements of Section 13(a) or Section 15(d) of the
Securities Exchange Act of 1934; as amended,
and
|
|
|
(2)
|
The information contained in the
Report fairly presents, in all material respects, the financial condition
and results of operations of the
Company.
|
|
Date:
January 19, 2011
|
/s/
ALTON L. BOYNTON
|
|
Alton
L. Boynton
|
|
|
President
and Chief Executive Officer
|
|
|
(principal
executive officer and principal financial
officer)
|
The
foregoing certification is being furnished solely pursuant to Section 906
of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company
as part of the Report or as a separate disclosure document for purposes of
Section 18 or any other provision of the Securities Exchange Act of 1934,
as amended.